Topic Hub

Ethnicity Pioglitazone

4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.

4articles

31keywords mapped

2026-05-27latest review

Explore

Ethnicity Pioglitazone library

Showing 4 of 4 clinical reviews.

Safety2026-05-27

Actos (Pioglitazone) East Asian Dose Adjustments: Pharmacogenomics, Safety, and Clinical Guidance

Evidence-based guide to pioglitazone dose adjustments for East Asian patients, covering CYP2C8 metabolism, lower BMI thresholds, fracture risk, and pharmacogenomic considerations.

Read clinical review

Safety2026-05-27

Actos (Pioglitazone) Safety Profile Differences in East Asian Patients

Evidence-based review of pioglitazone pharmacogenomic and safety differences in East Asian populations, including dosing considerations, fracture risk, bladder cancer signals, and CYP2C8 metabolism variations.

Read clinical review

Questions2026-05-27

Pioglitazone (Actos) in Black / African Ancestry Patients: Documented Efficacy Gaps and Pharmacogenomic Considerations

Evidence-based review of how pioglitazone (Actos) performs in Black and African ancestry populations, including pharmacogenomic differences, dosing considerations, and clinical trial subgroup data.

Read clinical review

Clinical Reviews2026-05-27

Pioglitazone (Actos) in Hispanic and Latino Patients: Documented Efficacy Differences

Evidence-based review of how pioglitazone performs in Hispanic and Latino populations, covering pharmacogenomic variants, insulin resistance phenotypes, ethnicity-stratified trial data, and clinical dosing guidance.

Read clinical review